Finance

Lists
T5O:FRA
bioXXmed AG
€0.95
0.00%
(0.00) 1D
Aug 26, 3:38:36 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for T5O...
Mkt. cap
231.58K
Avg. vol.
103.00
Volume
0.00
52-wk high
€1.36
52-wk low
€0.76
Shares outstanding
2.33M
No. of employees
2
Mkt. cap
231.58K
Avg. vol.
103.00
Volume
0.00
52-wk high
€1.36
52-wk low
€0.76
Shares outstanding
2.33M
No. of employees
2
About bioXXmed AG
CEO-
Employees2
Founded2000
Headquarters-
SectorBiotechnology
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
8.50K
8.50K
-134.00
-134.00
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.50K
6.50K
8.67K
8.67K
Operating expense
138.00K
138.00K
5.98K
5.98K
Total operating expenses
138.00K
138.00K
5.98K
5.98K
Operating income
-129.50K
-129.50K
-6.11K
-6.11K
Other non operating income
3.00K
3.00K
3.72K
3.72K
EBT including unusual items
-128.00K
-128.00K
-54.74K
-54.74K
EBT excluding unusual items
-128.00K
-128.00K
-4.74K
-4.74K
Income tax expense
-
-
-46.00
-46.00
Effective tax rate
-
-
0.08%
0.08%
Other operating expenses
85.00K
85.00K
43.79K
43.79K
Net income
-128.00K
-128.00K
-54.70K
-54.70K
Net profit margin
-1,505.88%
-1,505.88%
40,817.16%
40,817.16%
Earnings per share
-
-
-
-
Interest and investment income
-
-
38.00
38.00
Interest expense
-1.50K
-1.50K
-2.38K
-2.38K
Net interest expenses
-1.50K
-1.50K
-2.34K
-2.34K
Depreciation and amortization charges
46.50K
46.50K
-46.48K
-46.48K
EBITDA
-129.48K
-129.48K
-6.09K
-6.10K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps